SS
Swati Sandesh Mayekar
About Swati Sandesh Mayekar
Data last updated:
Swati Sandesh Mayekar is a Director at Arysta Lifescience India Limited (since 2020), Director at Equipoise Capital Management Private Limited (since 2019) and Director at Prodigy Finvest Pvt Ltd (since 1993), and holds 4 more current directorships. The companies operate in Agriculture, Financial Services and Healthcare. The 5 current companies with reported revenue have a combined latest revenue of ₹1,691 Cr; the largest is Arysta Lifescience India Limited at ₹1,689 Cr (FY 2023). Earlier, Swati Sandesh Mayekar was an Additional Director at Uniphos Enterprises Limited (2010) and Additional Director at Fdc Limited (2014–2015) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 May 2020 | 1949 | ₹1,689 Cr (FY 2023) | Active | |
| Director | 30 May 2019 | 2019 | ₹1.27 Cr (FY 2025) | Active | |
| Director | 20 Jul 1993 | 1993 | ₹25.7 Lakh (FY 2024) | Active | |
| Director | 17 Apr 1997 | 1997 | ₹17.1 Lakh (FY 2024) | Active | |
| Director | 30 Jun 2022 | 2022 | ₹4.1 Lakh (FY 2025) | Active | |
| Partner | 10 Jun 2019 | 2019 | Active | ||
| Director | 06 Jun 2013 | 2013 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 28 Jan 2010 | 1969 | ₹57.23 Cr (FY 2026) | Active | |
| Additional Director | 06 Sep 2014 | 1940 | ₹2,199 Cr (FY 2025) | Active | |
| Director | 28 Sep 2019 | 2018 | ₹1.5 Lakh (FY 2022) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Swati Sandesh Mayekar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Dobhal | 08502999 | Arysta Lifescience India Limited | Director |
| Meena Deepak Ved | 07706272 | Arysta Lifescience India Limited | Director |
| Ravishankar Cherukuri | 06755061 | Arysta Lifescience India Limited | Additional Director |
| Sameer Tandon | 05182038 | Arysta Lifescience India Limited | Director |
| Ashish Avinash Wakankar | 08505606 | Equipoise Capital Management Private Limited | Director |
| Karalyn Theresa Hendricks | 08505571 | Equipoise Capital Management Private Limited | Director |
| Sethuram Neelakantan Iyer | 05253455 | Equipoise Capital Management Private Limited | Director |
| Supriya Sanjay Panse | 07058011 | Equipoise Capital Management Private Limited , S Panse & Co Llp | Director |
| Ananya Akash Rao | 03038286 | Prodigy Finvest Pvt Ltd | Additional Director |
| Sandesh Madhukar Mayekar | 00245337 | Prodigy Finvest Pvt Ltd , Encode Advanced Dentistry Private Limited and 1 more | Director |
| Ketaki Hiraman Pawar | 09658463 | Taughtwell Simplifyed Private Limited | Director |
| Sanjay Dattatray Panse | 02725875 | S Panse & Co Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Swati Sandesh Mayekar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swati Sandesh Mayekar
Swati Sandesh Mayekar currently holds 7 directorships: Arysta Lifescience India Limited (Director, since 18 May 2020, revenue ₹1,689 Cr (FY 2023)); Equipoise Capital Management Private Limited (Director, since 30 May 2019, revenue ₹1.27 Cr (FY 2025)); Prodigy Finvest Pvt Ltd (Director, since 20 Jul 1993, revenue ₹25.7 Lakh (FY 2024)); Encode Advanced Dentistry Private Limited (Director, since 17 Apr 1997, revenue ₹17.1 Lakh (FY 2024)); Taughtwell Simplifyed Private Limited (Director, since 30 Jun 2022, revenue ₹4.1 Lakh (FY 2025)); and 2 more.
Swati Sandesh Mayekar was first appointed on 20 Jul 1993 as Director at Prodigy Finvest Pvt Ltd. The most recent appointment on record is 30 Jun 2022 at Taughtwell Simplifyed Private Limited.
The 5 current companies of Swati Sandesh Mayekar that report revenue have a combined latest revenue of ₹1,691 Cr: Arysta Lifescience India Limited ₹1,689 Cr (FY 2023); Equipoise Capital Management Private Limited ₹1.27 Cr (FY 2025); Prodigy Finvest Pvt Ltd ₹25.7 Lakh (FY 2024); Encode Advanced Dentistry Private Limited ₹17.1 Lakh (FY 2024); Taughtwell Simplifyed Private Limited ₹4.1 Lakh (FY 2025).
Swati Sandesh Mayekar held 3 earlier board appointments: Uniphos Enterprises Limited (Additional Director, 28 Jan 2010 to 08 Sep 2010); Fdc Limited (Additional Director, 06 Sep 2014 to 30 Sep 2015); Matra Technologies Private Limited (Director, from 28 Sep 2019).
The current boards of Swati Sandesh Mayekar's companies include Ashish Dobhal (Arysta Lifescience India Limited), Meena Deepak Ved (Arysta Lifescience India Limited), Ravishankar Cherukuri (Arysta Lifescience India Limited), Sameer Tandon (Arysta Lifescience India Limited), Ashish Avinash Wakankar (Equipoise Capital Management Private Limited), Karalyn Theresa Hendricks (Equipoise Capital Management Private Limited), among others.